| Peer-Reviewed

Level, Experiences and Manifestations of Community TB-Related Stigma in Tanzania

Received: 30 March 2023     Accepted: 4 May 2023     Published: 27 July 2023
Views:       Downloads:
Abstract

Background: Tuberculosis (TB) is an infectious disease of public importance worldwide including Tanzania. There is increasing recognition that TB-related stigma is a barrier to TB control and prevention. However, there is a paucity of information about community TB-related stigma in our settings. This study was objected to assess the level, experiences, and manifestations of community TB-related stigma. Methods: Between September 2021 and February 2022, a cross-sectional study was conducted to collect quantitative and qualitative information about community TB-related stigma in five regions of Tanzania. Face-to-face interviews were used to collect data among community members using a modified questionnaire to assess community TB stigma created by the Stop TB Partnership. Descriptive statistics and thematic analysis were used to summarize and present findings of this study. Results: One hundred seventy-one (171) community members were recruited. The overall level of community TB-related stigma was 71.5%. The TB stigma was mainly characterized by supporting behaviours and attitudes that limit contact with TB patients. Sixty-three percent (63%) of the community members experienced community members being stigmatized because of their TB status. The common manifestations of community TB-related stigma were isolation, mistreatment, being denied supports, and refusing to share housing, eating and drinking utensils. Conclusion: This study showed a relatively high level of community TB-related stigma in Tanzania, suggesting the need to include TB stigma reduction interventions in national TB control and prevention response strategies.

Published in European Journal of Preventive Medicine (Volume 11, Issue 4)
DOI 10.11648/j.ejpm.20231104.13
Page(s) 53-59
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Tuberculosis, Stigma, Community, Manifestations, Tanzania

References
[1] World Health Organization. Global Tuberculosis report 2022 [Internet]. Vol. 21. Geneva; 2022. Available from: http://journal.um-surabaya.ac.id/index.php/JKM/article/view/2203
[2] World Health Organization TSTI. The economic impacts of tuberculosis. In: Larson H, editor. AIP Conference Proceedings. Geneva; 2000. p. 382–5.
[3] Shete PB, Reid M, Goosby E. Message to world leaders: we cannot end tuberculosis without addressing the social and economic burden of the disease. Lancet Glob Heal [Internet]. 2018; 6 (12): e1272–3. Available from: http://dx.doi.org/10.1016/S2214-109X(18)30378-4
[4] Craig GM, Daftary A, Engel N, Driscoll SO, Ioannaki A. TB Stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. Int J Infect Dis [Internet]. 2016; S1201-9712 (16): 1–44. Available from: http://dx.doi.org/10.1016/j.ijid.2016.10.011
[5] Thomas BE, Stephen A. Tuberculosis related stigma in India: roadblocks and the way forward. Expert Rev Respir Med [Internet]. 2021; 15 (7): 859–61. Available from: https://doi.org/10.1080/17476348.2020.1826314
[6] Daftary A, Frick M, Venkatesan N, Pai M. Fighting TB stigma: We need to apply lessons learnt from HIV activism. BMJ Glob Heal. 2017; 2 (4): 4–7.
[7] United Nations. Resolution A/RES/73/3 adopted by the United Nations General Assembly on 10 October 2018 following approval by the high-level meeting of the General Assembly on the fight against tuberculosis on 26 September 2018. United Nations [Internet]. 2018;(September). Available from: https://undocs.org/en/A/RES/74/2
[8] Association AP. The stigma of disease and disability: Understanding causes and overcoming injustices [Internet]. 2014 [cited 2023 Mar 22]. p. 9–34. Available from: https://pycnet.apa.org/PsycBOOKS/toc/14297
[9] Centre for Addiction and Mental Health. The effects of prejudice and discrimination Prejudice on people with mental health and substance use problems [Internet]. Toronto: Online store: http://store.camh.ca; 2007 [cited 2023 Mar 22]. p. 1–4. Available from: https://psycnet.apa.org/PsycBOOKS/toc/14297
[10] Stangl AL, Earnshaw VA, Logie CH, Brakel W Van, Simbayi LC, Barré I, et al. The Health Stigma and Discrimination Framework : a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. 2019; 17 (31): 18–23.
[11] Courtwright A, Turner AN. Tuberculosis and stigmatization: Pathways and interventions. Public Health Rep. 2010; 125 (SUPPL. 4): 34–42.
[12] Mukerji R, Turan JM. Exploring manifestations of tb-related stigma experienced by women in Kolkata, India. Ann Glob Heal. 2018; 84 (4): 727–35.
[13] Dodor EA. An exploration of the causes, manifestations and consequences of tuberculosis stigma in an urban district in Ghana Emmanuel Atsu Dodor (BSc. MB ChB. MPH) [Internet]. University of Nottingham; 2009. Available from: https://eprints.nottingham.ac.uk/10846/1/Dr_EA_Dodor-_Submitted_Version_of_PhD_Thesis.pdf
[14] Mbuthia GW, Nyamogoba HDN, Chiang SS, McGarvey ST. Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study. PLoS One [Internet]. 2020; 15 (10 October): 1–14. Available from: http://dx.doi.org/10.1371/journal.pone.0240457
[15] Woith WM, Rappleyea ML. Journal of Health Psychology. 2014;
[16] Health MOF. National Tuberculosis and Leprosy Programme, annual report 2021 [Internet]. DODOMA; 2021. Available from: file:///C:/Users/LENOVO/Desktop/European journal of preventive Medicine/Articles-community TB stigma/ntlp_annual_report_2021_final_1.pdf
[17] Mangesho PE, Shayo E, Makunde WH, Mandara CI, Kamugisha ML. Commnity knowledge, attitudes and practices towards tberculosis and its treatment in Mpwapwa District, central Tanzania. 2007; 9 (1): 38–43.
[18] Miller C, Huston J, Samu L, Mfinanga S, Hopewell P, Fair E. “It makes the patient’s spirit weaker”: Tuberculosis stigma and gender interaction in Dar es Salaam, Tanzania. Int J Tuberc Lung Dis. 2017; 21 (December 2016): S42–8.
[19] STOP TB Partnership. TB STIGMA ASSESSMENT GUIDANCE. The Hague; 2018. 1–54 p.
[20] Redwood L, Mitchell EMH, Nguyen TA, Viney K, Duong L, Phạm HT, et al. Adaptation and validation of the Van Rie tuberculosis stigma scale in Vietnam. Int J Infect Dis. 2022; 114: 97–104.
[21] Sagili KD, Satyanarayana S, Chadha SS. Is Knowledge Regarding Tuberculosis Associated with Stigmatising and Discriminating Attitudes of General Population towards Tuberculosis Patients? Findings from a Community Based Survey in 30 Districts of India. PLoS One. 2016; 11 (2): 1–11.
[22] CO 100% LIFE. TB STIGMA ASSESSMENT IN UKRAINE [Internet]. 2021. Available from: https://www.uiphp.org.ua/media/k2/attachments/Zvit_100Life_Stigma_TB_ENG.pdf
[23] National TB Control Program anNational TB Control Program and Ghana-West Africa Program to Combat AIDS and STI (WAPCAS)., STI SG-WAP to CA and. Assessing the Stigma of Tuberculosis in Ghana: Consequences to Accessing and Provision of Services [Internet]. 2020. Available from: et/files/TB-Stigma-Index-Ghana-2020.pdf
[24] Kuo A, Teo J, Kay R, Tan J, Smyth C, Soltan V, et al. Characterizing and Measuring Tuberculosis Stigma in the Community : A Mixed-Methods Study in Cambodia. Infect Dis Soc Am. 2020; 1–10.
[25] Oladele DA, Balogun MR, Odeyemi K, Salako BL. Research Article A Comparative Study of Knowledge, Attitude, and Determinants of Tuberculosis-Associated Stigma in Rural and Urban Communities of Lagos State, Nigeria. Hindawi, Tuberc Res Treat. 2020; 2020: 14.
[26] Nofalia I. A Systematic Review of Stigma Among Tuberculosis Patient And Its Effect. Int J Psychosoc Rehabil. 2020; 24 (7): 9116–25.
[27] Moya EM, Lusk MW, Em M, Mw L. Tuberculosis stigma and perceptions in the US-Mexico border. 2013; 55 (1).
[28] Chakrabartty A, Basu P, Ali KM, Ghosh D. Tuberculosis related stigma attached to the adherence of Directly Observed Treatment Short Course (DOTS) in West Bengal, India. Indian J Tuberc [Internet]. 2019; 66 (2): 259–65. Available from: https://doi.org/10.1016/j.ijtb.2019.03.005
[29] Garg T, Gupta V, Sen D, Verma M, Brouwer M, Mishra R, et al. Prediagnostic loss to follow-up in an active case finding tuberculosis programme: A mixed-methods study from rural Bihar, India. BMJ Open. 2020; 10 (5): 1–11.
[30] Alema HB, Hailemariam SA, Misgina KH, Weldu MG, Gebregergis YS, Mekonen GK, et al. Health care seeking delay among pulmonary tuberculosis patients in North West zone of Tigrai region, North Ethiopia. BMC Infect Dis. 2019; 19 (1): 1–8.
[31] Richard O, Abiodun H, Queen O, Seyi O, Lucia O, Oluremilekun K, et al. Role of treatment supporters beyond monitoring daily drug intake for TB-patients: Findings from a qualitative study in Nigeria. J Public Heal Epidemiol. 2017; 9 (4): 65–73.
[32] Giri OP, Kumar A, Giri VP, Nikhil N. Impact of Treatment Supporters on the Treatment Outcomes of Drug Resistant-Tuberculosis (DR-TB) Patients: A Retrospective Cohort Study. Cureus. 2022; 14 (c).
[33] Duko B, Bedaso A, Ayano G, Yohannis Z. Perceived Stigma and Associated Factors among Patient with Tuberculosis, Wolaita Sodo, Ethiopia: Cross-Sectional Study. Tuberc Res Treat. 2019; 2019: 1–5.
[34] Baral SC, Karki DK, Newell JN. Causes of stigma and discrimination associated with tuberculosis in Nepal: A qualitative study. BMC Public Health. 2007; 7: 1–10.
[35] Dodor EA, Neal K, Kelly S. An exploration of the causes of tuberculosis stigma in an urban district in Ghana. 2008; 12 (May): 1048–54.
Cite This Article
  • APA Style

    Wilbard Deogratius Muhandiki, Ndakibae Gabriel Mabega, Lucas Eliaimringi Matemba, Gerald Phares Mwing’a, Oscar Leonard Kaswaga, et al. (2023). Level, Experiences and Manifestations of Community TB-Related Stigma in Tanzania. European Journal of Preventive Medicine, 11(4), 53-59. https://doi.org/10.11648/j.ejpm.20231104.13

    Copy | Download

    ACS Style

    Wilbard Deogratius Muhandiki; Ndakibae Gabriel Mabega; Lucas Eliaimringi Matemba; Gerald Phares Mwing’a; Oscar Leonard Kaswaga, et al. Level, Experiences and Manifestations of Community TB-Related Stigma in Tanzania. Eur. J. Prev. Med. 2023, 11(4), 53-59. doi: 10.11648/j.ejpm.20231104.13

    Copy | Download

    AMA Style

    Wilbard Deogratius Muhandiki, Ndakibae Gabriel Mabega, Lucas Eliaimringi Matemba, Gerald Phares Mwing’a, Oscar Leonard Kaswaga, et al. Level, Experiences and Manifestations of Community TB-Related Stigma in Tanzania. Eur J Prev Med. 2023;11(4):53-59. doi: 10.11648/j.ejpm.20231104.13

    Copy | Download

  • @article{10.11648/j.ejpm.20231104.13,
      author = {Wilbard Deogratius Muhandiki and Ndakibae Gabriel Mabega and Lucas Eliaimringi Matemba and Gerald Phares Mwing’a and Oscar Leonard Kaswaga and Hamimu Omary Kigumi and Emmanuel Heriel Matechi and Onay Godson Lwanzali and Riziki Michael Kisonga and Mangi Job Ezekiel and Eliakimu Paul Kapyolo},
      title = {Level, Experiences and Manifestations of Community TB-Related Stigma in Tanzania},
      journal = {European Journal of Preventive Medicine},
      volume = {11},
      number = {4},
      pages = {53-59},
      doi = {10.11648/j.ejpm.20231104.13},
      url = {https://doi.org/10.11648/j.ejpm.20231104.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejpm.20231104.13},
      abstract = {Background: Tuberculosis (TB) is an infectious disease of public importance worldwide including Tanzania. There is increasing recognition that TB-related stigma is a barrier to TB control and prevention. However, there is a paucity of information about community TB-related stigma in our settings. This study was objected to assess the level, experiences, and manifestations of community TB-related stigma. Methods: Between September 2021 and February 2022, a cross-sectional study was conducted to collect quantitative and qualitative information about community TB-related stigma in five regions of Tanzania. Face-to-face interviews were used to collect data among community members using a modified questionnaire to assess community TB stigma created by the Stop TB Partnership. Descriptive statistics and thematic analysis were used to summarize and present findings of this study. Results: One hundred seventy-one (171) community members were recruited. The overall level of community TB-related stigma was 71.5%. The TB stigma was mainly characterized by supporting behaviours and attitudes that limit contact with TB patients. Sixty-three percent (63%) of the community members experienced community members being stigmatized because of their TB status. The common manifestations of community TB-related stigma were isolation, mistreatment, being denied supports, and refusing to share housing, eating and drinking utensils. Conclusion: This study showed a relatively high level of community TB-related stigma in Tanzania, suggesting the need to include TB stigma reduction interventions in national TB control and prevention response strategies.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Level, Experiences and Manifestations of Community TB-Related Stigma in Tanzania
    AU  - Wilbard Deogratius Muhandiki
    AU  - Ndakibae Gabriel Mabega
    AU  - Lucas Eliaimringi Matemba
    AU  - Gerald Phares Mwing’a
    AU  - Oscar Leonard Kaswaga
    AU  - Hamimu Omary Kigumi
    AU  - Emmanuel Heriel Matechi
    AU  - Onay Godson Lwanzali
    AU  - Riziki Michael Kisonga
    AU  - Mangi Job Ezekiel
    AU  - Eliakimu Paul Kapyolo
    Y1  - 2023/07/27
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ejpm.20231104.13
    DO  - 10.11648/j.ejpm.20231104.13
    T2  - European Journal of Preventive Medicine
    JF  - European Journal of Preventive Medicine
    JO  - European Journal of Preventive Medicine
    SP  - 53
    EP  - 59
    PB  - Science Publishing Group
    SN  - 2330-8230
    UR  - https://doi.org/10.11648/j.ejpm.20231104.13
    AB  - Background: Tuberculosis (TB) is an infectious disease of public importance worldwide including Tanzania. There is increasing recognition that TB-related stigma is a barrier to TB control and prevention. However, there is a paucity of information about community TB-related stigma in our settings. This study was objected to assess the level, experiences, and manifestations of community TB-related stigma. Methods: Between September 2021 and February 2022, a cross-sectional study was conducted to collect quantitative and qualitative information about community TB-related stigma in five regions of Tanzania. Face-to-face interviews were used to collect data among community members using a modified questionnaire to assess community TB stigma created by the Stop TB Partnership. Descriptive statistics and thematic analysis were used to summarize and present findings of this study. Results: One hundred seventy-one (171) community members were recruited. The overall level of community TB-related stigma was 71.5%. The TB stigma was mainly characterized by supporting behaviours and attitudes that limit contact with TB patients. Sixty-three percent (63%) of the community members experienced community members being stigmatized because of their TB status. The common manifestations of community TB-related stigma were isolation, mistreatment, being denied supports, and refusing to share housing, eating and drinking utensils. Conclusion: This study showed a relatively high level of community TB-related stigma in Tanzania, suggesting the need to include TB stigma reduction interventions in national TB control and prevention response strategies.
    VL  - 11
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Department of Research and Consultancy, Geita Health Training Institutes, Geita, United Republic of Tanzania

  • Department of Health Research Information and Regulatory Affairs, National Institute for Medical Research, Dar es Salaam, United Republic of Tanzania

  • Department of Clinical Research, National Institute for Medical Research, Dodoma Medical Research Centre, Dodoma, United Republic of Tanzania

  • Department of Clinical Research, National Institute for Medical Research, Dodoma Medical Research Centre, Dodoma, United Republic of Tanzania

  • Department of Mathematics and Statistics, University of Dodoma, Dodoma, United Republic of Tanzania

  • Department of Preventive Services, Ministry of Health, National Tuberculosis and Leprosy Programme, Dodoma, United Republic of Tanzania

  • Department of Preventive Services, Ministry of Health, National Tuberculosis and Leprosy Programme, Dodoma, United Republic of Tanzania

  • Department of Preventive Services, Ministry of Health, National Tuberculosis and Leprosy Programme, Dodoma, United Republic of Tanzania

  • Department of Preventive Services, Ministry of Health, National Tuberculosis and Leprosy Programme, Dodoma, United Republic of Tanzania

  • Department of Behavioral Science, Muhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania

  • Department of Clinical Research, National Institute for Medical Research, Dodoma Medical Research Centre, Dodoma, United Republic of Tanzania

  • Sections